Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)
Status:
Unknown status
Trial end date:
2020-05-31
Target enrollment:
Participant gender:
Summary
In ASCVD patients complicated with subclinical hypothyroidism, the percentage of those who
did not reach the target of lipid-lowering therapy (LDL-C>1.8mmol/L) is usually higher than
that in population with normal thyroid function. The present study aims to randomly compare
two lipid-lowering therapeutic strategies (statins only vs. statins combined with thyroid
hormone supplement).
Phase:
N/A
Details
Lead Sponsor:
China National Center for Cardiovascular Diseases Shaochun.Li
Collaborators:
Beijing Chao Yang Hospital Beijing Friendship Hospital Chinese Academy of Medical Sciences, Fuwai Hospital Peking University Third Hospital Xuanwu Hospital, Beijing